APTAMER GROUP PLC (APTA) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the APTAMER GROUP PLC Interim Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question or receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it is appropriate to do so. Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO, Aaron Tolley. Good afternoon to you. Hello. Good afternoon. Welcome to our interim results six months to the 12/31/2023. So presentation that we're gonna give today has got three broad sections to it. We'll first do an introduction, as usual, about the company and our technology. We'll then move on to our h one overview and talk about operational and financial progress, and then we'll talk about post period updates in terms of operations and technical progress. So my name's Aaron Tolley. I'm one of the cofounders of APTAMER GROUP, and I founded the company several years ago or many years ago now, in fact, with David when we recognized the gap in the market for affinity ligands, which we'll come on to talking about a bit later. Hi, everyone. I'm Dave Bunker. I'm the chief scientific officer, and as Aaron said, the the other cofounder of APTAMER GROUP. I've got a background in molecular biology, but it's really in APTAMER technologies. I've worked with this this platform for very nearly twenty five years, which is quite worrying for me. Andrew? Thanks, Dave. Good afternoon, everybody. I'm Andrew Repson. I'...